At close: 4:59 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
18,035,000.00
18,120,000.00
18,687,000.00
15,775,000.00
13,449,000.00
Cost of Revenue
8,685,000.00
9,175,000.00
9,555,000.00
7,093,000.00
6,151,000.00
Gross Profit
9,350,000.00
8,945,000.00
9,132,000.00
8,682,000.00
7,298,000.00
Operating Expense
7,983,000.00
8,137,000.00
8,012,000.00
6,289,000.00
5,667,000.00
Operating Income
1,367,000.00
808,000.00
1,120,000.00
2,393,000.00
1,631,000.00
Net Non Operating Interest Income Expense
-509,000.00
-459,000.00
-279,000.00
-58,000.00
-103,000.00
Pretax Income
906,000.00
343,000.00
725,000.00
2,271,000.00
1,612,000.00
Tax Provision
200,000.00
77,000.00
155,000.00
481,000.00
343,000.00
Net Income Common Stockholders
658,000.00
228,000.00
511,000.00
1,756,000.00
1,252,000.00
Diluted NI Available to Com Stockholders
658,000.00
228,000.00
511,000.00
1,756,000.00
1,252,000.00
Basic EPS
4.50
1.64
4.00
13.63
9.72
Diluted EPS
4.50
1.64
3.99
13.49
9.63
Basic Average Shares
145,606.75
138,883.00
127,823.00
128,816.00
128,805.00
Diluted Average Shares
145,723.75
138,991.00
128,126.00
130,194.00
130,032.00
Total Operating Income as Reported
1,436,000.00
869,000.00
1,111,000.00
2,397,000.00
1,627,000.00
Total Expenses
16,668,000.00
17,312,000.00
17,567,000.00
13,382,000.00
11,818,000.00
Net Income from Continuing & Discontinued Operation
658,000.00
228,000.00
511,000.00
1,756,000.00
1,252,000.00
Normalized Income
529,423.84
106,168.00
797,890.00
1,854,500.00
1,191,401.00
Interest Income
--
63,000.00
7,000.00
2,000.00
5,000.00
Interest Expense
--
326,000.00
186,000.00
91,000.00
68,000.00
Net Interest Income
-509,000.00
-459,000.00
-279,000.00
-58,000.00
-103,000.00
EBIT
1,228,000.00
669,000.00
911,000.00
2,362,000.00
1,680,000.00
EBITDA
2,897,000.00
2,398,000.00
2,445,000.00
3,554,000.00
2,847,000.00
Reconciled Cost of Revenue
8,685,000.00
9,175,000.00
9,555,000.00
7,093,000.00
6,151,000.00
Reconciled Depreciation
1,669,000.00
1,729,000.00
1,534,000.00
1,192,000.00
1,167,000.00
Net Income from Continuing Operation Net Minority Interest
658,000.00
228,000.00
511,000.00
1,756,000.00
1,252,000.00
Total Unusual Items Excluding Goodwill
165,000.00
157,000.00
-365,000.00
-125,000.00
77,000.00
Total Unusual Items
165,000.00
157,000.00
-365,000.00
-125,000.00
77,000.00
Normalized EBITDA
2,732,000.00
2,241,000.00
2,810,000.00
3,679,000.00
2,770,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
36,423.84
35,168.00
-78,110.00
-26,500.00
16,401.00
12/31/2020 - 10/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AMBU-B.CO Ambu A/S
113.05
-1.27%
DEMANT.CO Demant A/S
264.80
-0.15%
CHEMM.CO ChemoMetec A/S
432.60
-0.51%
EMBLA.CO Embla Medical hf
36.30
+1.11%
VIRO.CO ViroGates A/S
14.90
+16.41%
VITR.ST Vitrolife AB (publ)
219.00
+2.34%
MCAP.ST MedCap AB (publ)
525.00
+2.34%
SMSMED.CO Scandinavian Medical Solutions A/S
6.30
+5.00%
REG1V.HE Revenio Group Oyj
27.10
-4.98%
GETI-B.ST Getinge AB (publ)
171.10
-0.90%